Keep up with the latest happenings in Erba

Transasia graces 72nd Independence Day celebrations at AMTZ

Date : 15 Aug, 2018

Saluting the spirit of independence and Make in India initiative, Mr. Suresh Vazirani and Mrs. Mala Vazirani of Transasia Bio-Medicals Ltd, pioneers of Indian IVD industry, delivered a lecture at Andhra Pradesh Medtech Zone Ltd (AMTZ) on the occasion of 72nd Independence Day celebrations. The function started with the unfurling of the national flag through the hands of Dr. Jitendar Sharma, MD & CEO of AMTZ, and Mr. Vazirani. The ceremony took place in the presence of a large gathering of representatives from AMTZ as well as Transasia Bio-Medicals Ltd.

Later during the day, Mr. Suresh Vazirani, CMD of Transasia Bio-Medicals Ltd addressed the gathering on how he made manufacturing in India a reality. He emphasized on the need to manufacture medical devices in India to counter the dependency on imports. “ I feel proud to be a citizen of a progressive nation and I am glad that I am able to contribute to the health of this country. I started Transasia with a conviction that some day India would have its own indigenously manufactured medical devices that would meet the diagnostic needs of the country. I am happy that as India’s leading IVD Company, we have been successful in setting up four manufacturing facilities in India and provide employment to many,” he said. 

Mrs. Mala Vazirani, Executive Director, Transasia Bio-Medicals Ltd., further added, “ When we started off, we had a tough time convincing doctors, that an Indian manufactured instrument could work as efficiently as any other. In the last 40 years, we have come a long way, both of us, our senior management team and every member of the Transasia family.

Independence Day 2018

Today, with over 65,000 installations across India and the largest field force comprising sales and service experts, I am honored that Transasia is recognized as a trusted name not only in the country but also globally. We are glad to be associated with AMTZ in further strengthening the Make in India initiative.”

The session concluded with felicitation of Mr. Suresh Vazirani and Mrs. Mala Vazirani by Dr. Jitendar Sharma.

About Transasia Bio-Medicals Ltd.:

Founded in 1979, Transasia Bio-Medicals Ltd., India’s Leading In-vitro Diagnostic Company offers products and solutions in Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Diabetes Management, Microbiology and Molecular Diagnostics. 

Transasia provides doctors and patients with reliable, affordable and innovative Medical Diagnostic Systems, with an impressive install base of above 65,000 equipment across India. It has a vast network of the more than 300+ service and application support specialists, 400+ sales and marketing team, 24 zonal offices and 350+ distributors. 

It is the first Indian company to manufacture and export blood analyzers and reagents, in the 1990s. Today, Transasia’s indigenous research has resulted in development of state of the art, ‘Make in India’ products and technologies, enabling its products to be among the best in the world. 

All along its journey spanning more than three decades, Transasia has been recognized for its commitment to healthcare. The Govt. of India recently bestowed Transasia with ‘The India Medical Devices Export Company of the Year’ award amongst many others. Besides this, Transasia was conferred the Best Medical Equipment Company of the Year-2017’ by Medgate Today and the ‘Economic Times- Best Healthcare Brand 2016’ amongst many others. 

Headquartered in Mumbai, Transasia is a part of the global Erba Diagnostics Mannheim GmbH Group. The Erba –Transasia Group has spread its footprint across USA, UK, Germany, Czech Republic, France, Italy, Russia and Turkey through various acquisitions. 

Erba’s production sites in India, Czech Republic and USA and R&D centres in France, UK, India and Czech Republic form a hub for indigenous manufacturing of world class deliverables.Today, the Erba -Transasia Group serves millions across 100 countries. For further information, kindly visit